MELBOURNE, Australia, July 18, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and ...
(RTTNews) - Quest Diagnostics (DGX) announced the launch of a new obstetrics laboratory test panel designed to enable physicians to screen all eligible pregnant people for hepatitis C with other ...
SECAUCUS, NJ / ACCESSWIRE / October 17, 2022 / Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, recently announced the launch of a new obstetrics ...
Quest Diagnostics launched an obstetrics test panel for screening pregnant people for hepatitis C. The panel is designed to facilitate easy and reliable screening for hepatitis C with other lab tests ...
To provide the clinical experience, curricular programming, mentorship, research opportunities, and resources to produce physicians committed to providing comprehensive, compassionate, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback